| Financial Year |
March 31 2023 |
| Monetary Funds |
517,107,276.86 |
| Held-for-trading Financial Assets |
247,225,340.97 |
| Notes Receivable |
-- |
| Accounts Receivable |
249,642,683.12 |
| Advances to Suppliers |
63,999,318.35 |
| Other Receivables |
45,892,822.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
202,693,832.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
116,952,183.29 |
| Total Current Assets |
1,476,263,940.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
463,857,362.79 |
| Under-construction Projects |
496,701,005.62 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,522,809.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,071,073.83 |
| Deferred Income Tax Assets |
12,116,225.23 |
| Other Non-Current Assets |
45,260,233.64 |
| Sub-Total of Non-Current Assets |
1,403,372,500.12 |
| Total Assets |
2,879,636,440.14 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
123,463,200.00 |
| Accounts Payable |
92,344,606.50 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,311,659.11 |
| Taxes Payable |
25,501,754.31 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,002,287.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
27,820,481.70 |
| Other Current Liabilities |
3,345,283.78 |
| Sub-Total of Current Liabilities |
321,476,461.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
237,296.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,522,791.60 |
| Total Liabilities |
460,999,253.27 |
| Paid-In Capital(Or Share Stock) |
217,410,000.00 |
| Capital Surplus |
1,014,917,222.83 |
| Surplus Reserve |
137,660,156.81 |
| LESS:Treasury Stock |
72,994,058.84 |
| Undistributed Profits |
1,124,882,890.66 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,418,637,186.87 |
| Owner's Equity（Stockholder's Equity） |
2,418,637,186.87 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,879,636,440.14 |
